
Shobha Kantamneni
Examiner (ID: 1732, Phone: (571)272-2930 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627, 1617, 1623 |
| Total Applications | 1212 |
| Issued Applications | 306 |
| Pending Applications | 120 |
| Abandoned Applications | 793 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6830469
[patent_doc_number] => 20030181527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Novel formulations of alpha-2,4-disulfophenyl-n-tert-butylnitrone'
[patent_app_type] => new
[patent_app_number] => 10/276747
[patent_app_country] => US
[patent_app_date] => 2002-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5907
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181527.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276747
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276747 | Novel formulations of alpha-2,4-disulfophenyl-n-tert-butylnitrone | Nov 17, 2002 | Abandoned |
Array
(
[id] => 6684052
[patent_doc_number] => 20030119916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Treatment of functional gastrointestinal disorders'
[patent_app_type] => new
[patent_app_number] => 10/220544
[patent_app_country] => US
[patent_app_date] => 2002-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1864
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119916.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220544
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220544 | Treatment of functional gastrointestinal disorders | Nov 17, 2002 | Abandoned |
Array
(
[id] => 6697310
[patent_doc_number] => 20030109504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Treatment of movement disorders with metabotropic glutamate receptors antagonist'
[patent_app_type] => new
[patent_app_number] => 10/239710
[patent_app_country] => US
[patent_app_date] => 2002-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5098
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109504.pdf
[firstpage_image] =>[orig_patent_app_number] => 10239710
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/239710 | Treatment of movement disorders with metabotropic glutamate receptors antagonist | Nov 13, 2002 | Abandoned |
Array
(
[id] => 6856743
[patent_doc_number] => 20030130244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Compositions for treatment of postmenopausal female sexual dysfunction'
[patent_app_type] => new
[patent_app_number] => 10/292742
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5512
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130244.pdf
[firstpage_image] =>[orig_patent_app_number] => 10292742
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/292742 | Compositions for treatment of postmenopausal female sexual dysfunction | Nov 11, 2002 | Abandoned |
Array
(
[id] => 6682769
[patent_doc_number] => 20030118633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Combination therapy'
[patent_app_type] => new
[patent_app_number] => 10/289903
[patent_app_country] => US
[patent_app_date] => 2002-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1941
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20030118633.pdf
[firstpage_image] =>[orig_patent_app_number] => 10289903
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/289903 | Combination therapy | Nov 6, 2002 | Abandoned |
| 60/608961 | Hormone replacement therapy with cardiovascular protection using antialdosteronic progestins | Nov 4, 2002 | Pending |
Array
(
[id] => 6852149
[patent_doc_number] => 20030144352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Antimuscarinic aerosol'
[patent_app_type] => new
[patent_app_number] => 10/287061
[patent_app_country] => US
[patent_app_date] => 2002-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4944
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20030144352.pdf
[firstpage_image] =>[orig_patent_app_number] => 10287061
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/287061 | Antimuscarinic aerosol | Nov 3, 2002 | Abandoned |
Array
(
[id] => 6865584
[patent_doc_number] => 20030191110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Modulators of the cholesterol biosynthetic pathway'
[patent_app_type] => new
[patent_app_number] => 10/286416
[patent_app_country] => US
[patent_app_date] => 2002-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19117
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191110.pdf
[firstpage_image] =>[orig_patent_app_number] => 10286416
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/286416 | Modulators of the cholesterol biosynthetic pathway | Oct 31, 2002 | Abandoned |
Array
(
[id] => 6860520
[patent_doc_number] => 20030091528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Transparent liquid composition'
[patent_app_type] => new
[patent_app_number] => 10/258430
[patent_app_country] => US
[patent_app_date] => 2002-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4016
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20030091528.pdf
[firstpage_image] =>[orig_patent_app_number] => 10258430
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/258430 | Transparent liquid composition | Oct 22, 2002 | Abandoned |
Array
(
[id] => 6669535
[patent_doc_number] => 20030114519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition'
[patent_app_type] => new
[patent_app_number] => 10/276112
[patent_app_country] => US
[patent_app_date] => 2002-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3727
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20030114519.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276112
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276112 | Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition | Oct 21, 2002 | Abandoned |
Array
(
[id] => 6856748
[patent_doc_number] => 20030130249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Therapeutic use of estrogen receptor (ER)beta-selective agonists for triggering somatotropic, organotropic and anticatabolic effects (somatotropic therapy)'
[patent_app_type] => new
[patent_app_number] => 10/272290
[patent_app_country] => US
[patent_app_date] => 2002-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7232
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130249.pdf
[firstpage_image] =>[orig_patent_app_number] => 10272290
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/272290 | Therapeutic use of estrogen receptor (ER)beta-selective agonists for triggering somatotropic, organotropic and anticatabolic effects (somatotropic therapy) | Oct 16, 2002 | Abandoned |
Array
(
[id] => 6669490
[patent_doc_number] => 20030114474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors'
[patent_app_type] => new
[patent_app_number] => 10/268543
[patent_app_country] => US
[patent_app_date] => 2002-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7075
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20030114474.pdf
[firstpage_image] =>[orig_patent_app_number] => 10268543
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/268543 | Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors | Oct 9, 2002 | Abandoned |
Array
(
[id] => 6865570
[patent_doc_number] => 20030191096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Method of hormonal therapy'
[patent_app_type] => new
[patent_app_number] => 10/268008
[patent_app_country] => US
[patent_app_date] => 2002-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4238
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191096.pdf
[firstpage_image] =>[orig_patent_app_number] => 10268008
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/268008 | Method of hormonal therapy | Oct 8, 2002 | Abandoned |
Array
(
[id] => 6818210
[patent_doc_number] => 20030069168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Immunosuppressive agents'
[patent_app_type] => new
[patent_app_number] => 10/265612
[patent_app_country] => US
[patent_app_date] => 2002-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7959
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20030069168.pdf
[firstpage_image] =>[orig_patent_app_number] => 10265612
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/265612 | Immunosuppressive agents | Oct 7, 2002 | Abandoned |
Array
(
[id] => 6835231
[patent_doc_number] => 20030162777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Novel N-acylated heterocycles'
[patent_app_type] => new
[patent_app_number] => 10/266104
[patent_app_country] => US
[patent_app_date] => 2002-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 72083
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162777.pdf
[firstpage_image] =>[orig_patent_app_number] => 10266104
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/266104 | Novel N-acylated heterocycles | Oct 6, 2002 | Abandoned |
Array
(
[id] => 6664557
[patent_doc_number] => 20030203883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => '2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations'
[patent_app_type] => new
[patent_app_number] => 10/264187
[patent_app_country] => US
[patent_app_date] => 2002-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37723
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203883.pdf
[firstpage_image] =>[orig_patent_app_number] => 10264187
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/264187 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations | Oct 2, 2002 | Abandoned |
| 10/048631 | Method for increasing optic nerve, choroidal and retinal blood flow to facilitate the preservation of sight | Sep 29, 2002 | Abandoned |
Array
(
[id] => 6801632
[patent_doc_number] => 20030096797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Novel pharmaceutical formulations comprising aminoalkyl phosphorothioates'
[patent_app_type] => new
[patent_app_number] => 10/254673
[patent_app_country] => US
[patent_app_date] => 2002-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9311
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096797.pdf
[firstpage_image] =>[orig_patent_app_number] => 10254673
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/254673 | Novel pharmaceutical formulations comprising aminoalkyl phosphorothioates | Sep 25, 2002 | Abandoned |
Array
(
[id] => 6640641
[patent_doc_number] => 20030212121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents'
[patent_app_type] => new
[patent_app_number] => 10/253910
[patent_app_country] => US
[patent_app_date] => 2002-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10775
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212121.pdf
[firstpage_image] =>[orig_patent_app_number] => 10253910
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/253910 | Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents | Sep 24, 2002 | Issued |
Array
(
[id] => 6797440
[patent_doc_number] => 20030176314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Compounds for the treatment of pain'
[patent_app_type] => new
[patent_app_number] => 10/253237
[patent_app_country] => US
[patent_app_date] => 2002-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 34964
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176314.pdf
[firstpage_image] =>[orig_patent_app_number] => 10253237
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/253237 | Compounds for the treatment of pain | Sep 23, 2002 | Abandoned |